Otsuka Hits Indian Pharma Co. With IP Suit Over Kidney Drug

By Britain Eakin · June 24, 2021, 5:59 PM EDT

Otsuka Pharmaceutical Co. has sued Indian drug manufacturer Lupin for patent infringement over a planned generic version of Otsuka's kidney treatment drug Jynarque, which is used to treat patients suffering from...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Case Information

Case Title

Plaintiff(s) v. Defendant(s)

Case Number

Court

Delaware

Nature of Suit

Other Statutory Actions

Date Filed

January 01, 2025

Recent Articles By Britain

March 12, 2025
Trump Admin Seeks To End ACA Access For 'Dreamers'
October 30, 2024
Access To 'Dreamer' Info Limited In Suit Over HHS Rule
August 22, 2024
2nd Circ. Says Feds Can't Forcibly Drug Man Facing Removal
August 14, 2024
GSA Hit With Protest Over $985M Migrant Kid Transport Deal
June 27, 2024
Ga. Judge Says NBC Falsely Reported Mass Hysterectomies
May 30, 2024
Full 9th Circ. Won't Rehear Immigration Attys' Privacy Row
January 31, 2024
Final Immigration Fee Hikes Seen As 'Tax' On Employers
December 08, 2023
How Immigration Can Fill Labor Gaps — A Series
December 01, 2023
Special Visas Needed To Address Health Labor Shortages
November 30, 2023
DOL Board Says Labor Shortage Can't Justify H-2B Caregivers